Patents-Review.com
ClassID:

21193 ⎘

A61K2039/55538 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants; Cytokines; Lymphokines; Interferons; Interleukins IL-12

Recent Application in this class:
#1
20260130978
2026-05-14

Ultrapurified Phospholipoproteomic Composition for High-Purity Biomolecular Research and Precision Therapeutics

 #2
20260053908
2026-02-26

Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

 #3
20250375512
2025-12-11

USE OF MATRIX BOUND VESICLES (MBV) AS VACCINE ADJUVANTS

 #4
20250360206
2025-11-27

CANCER ANTIGENS AND METHODS

 #5
20250339510
2025-11-06

POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME

 #6
20250332250
2025-10-30

VACCINE COMPOSITION OR KIT FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE, CONTAINING GENETIC MATERIAL THAT ENCODES FOREIGN ANTIGEN

 #7
20250332235
2025-10-30

BREAST CANCER TUMOR CELL VACCINES

 #8
20250302931
2025-10-02

COLORECTAL CANCER TUMOR CELL VACCINES

 #9
20250257101
2025-08-14

Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using Same

 #10
20250213724
2025-07-03

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

 #11
20250177515
2025-06-05

METHODS AND COMPOSITIONS RELATING TO IMMUNIZATION OF IMMUNE DISTINCT PATIENTS

 #12
20250041406
2025-02-06

RECOMBINANT MULTIVALENT VACCINE

 #13
20250041394
2025-02-06

IMMUNOSTIMULATORY MRNA COMPOSITIONS AND USES THEREOF

 #14
20240285741
2024-08-29

CANCER VACCINES TARGETING MESOTHELIN AND USES THEREOF

 #15
20240158802
2024-05-16

MRNA TREATMENT NANOPARTICLES

 #16
20240066127
2024-02-29

IL-12 POLYPEPTIDES, IL-15 POLYPEPTIDES, IL-18 POLYPEPTIDES, CD8 POLYPEPTIDES, COMPOSITIONS, AND METHODS OF USING THEREOF

 #17
20240016925
2024-01-18

NOVEL VACCINE ADJUVANT

 #18
20240016908
2024-01-18

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

 #19
20230414744
2023-12-28

Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

 #20
20230348548
2023-11-02

MEMBRANE-BOUND IL-15, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF

 #21
20230346935
2023-11-02

TUMOR COMPLEX ANTIGEN, MULTIVALENT DENDRITIC CELL (DC) VACCINE, AND USE THEREOF

 #22
20230285460
2023-09-14

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

 #23
20230279424
2023-09-07

COMBINATION CYTOKINES FOR METHODS AND COMPOSITIONS FOR TREATING CANCER

 #24
20230190902
2023-06-22

IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES, PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF CANCER EXPRESSING PRAME

 #25
20230145774
2023-05-11

TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION

 #26
20230142916
2023-05-11

ALL-IN ONE VECTOR FOR CAR AND THERAPEUTIC EFFECTOR MOLECULE

 #27
20220378906
2022-12-01

Compositions, methods and kits for eliciting an immune response

 #28
20220370581
2022-11-24

VACCINE AND METHOD FOR TREATING CANCER

 #29
20220331415
2022-10-20

IMMUNOACTIVE MICROPARTICLES AND USES THEREOF

 #30
20220273784
2022-09-01

Methods and compositions for liquidation of tumors

 #31
20220265820
2022-08-25

TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES

 #32
20220265801
2022-08-25

Cancer Vaccines Targeting PRAME and Uses Thereof

 #33
20220259300
2022-08-18

VACCINE COMPOSITION COMPRISING A MUTANT OF HUMAN INTERLEUKIN-15

 #34
20220226448
2022-07-21

ONE-STEP ARTIFICIAL ANTIGEN PRESENTING CELL-BASED VACCINES

 #35
20220193230
2022-06-23

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

 #36
20220133869
2022-05-05

BREAST CANCER TUMOR CELL VACCINES

 #37
20220133868
2022-05-05

TUMOR CELL VACCINES

 #38
20220088186
2022-03-24

SAMRNA VACCINE AND PREPARATION METHOD THEREFOR

 #39
20220054611
2022-02-24

PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER

 #40
20220000922
2022-01-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #41
20210401965
2021-12-30

DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)

 #42
20210401959
2021-12-30

Cancer vaccines targeting mesothelin and uses thereof

 #43
20210401892
2021-12-30

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #44
20210388033
2021-12-16

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

 #45
20210353736
2021-11-18

Vaccines for recurrent respiratory papillomatosis and methods of using the same

 #46
20210353729
2021-11-18

Cancer antigens and methods

 #47
20210338735
2021-11-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #48
20210338734
2021-11-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #49
20210330708
2021-10-28

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #50
20210300968
2021-09-30

Uterine cancer treatments

 #51
20210260120
2021-08-26

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #52
20210244765
2021-08-12

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #53
20210236626
2021-08-05

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes

 #54
20210213064
2021-07-15

Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers

 #55
20210154291
2021-05-27

Immunostimulatory compositions, particles, and uses related thereto

 #56
20210145888
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #57
20210145887
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #58
20210145886
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #59
20210137986
2021-05-13

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #60
20210137985
2021-05-13

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #61
20210113619
2021-04-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #62
20210100845
2021-04-08

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #63
20210069251
2021-03-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #64
20210060078
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #65
20210060077
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #66
20210060074
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #67
20210052654
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #68
20210052653
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #69
20210052652
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #70
20210052651
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #71
20200360514
2020-11-19

Vaccine adjuvant

 #72
20200360433
2020-11-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #73
20200323919
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #74
20200323918
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #75
20200323916
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #76
20200323915
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #77
20200323914
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #78
20200323913
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #79
20200323911
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #80
20200323910
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #81
20200323909
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #82
20200323907
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #83
20200323906
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #84
20200306311
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #85
20200306308
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #86
20200306305
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #87
20200297772
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #88
20200297771
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #89
20200297770
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #90
20200268800
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #91
20200268799
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #92
20200268798
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #93
20200261506
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #94
20200261505
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #95
20200261504
2020-08-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #96
20200222465
2020-07-16

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #97
20200206268
2020-07-02

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #98
20200197441
2020-06-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #99
20200181254
2020-06-11

VACCINE COMPOSITION COMPRISING A MUTANT OF HUMAN INTERLEUKIN-15

 #100
20200179454
2020-06-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #101
20200179453
2020-06-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #102
20200171091
2020-06-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #103
20200163996
2020-05-28

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #104
20200155605
2020-05-21

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #105
20200155604
2020-05-21

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #106
20200129607
2020-04-30

Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes

 #107
20200108097
2020-04-09

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #108
20200093862
2020-03-26

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #109
20200085874
2020-03-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #110
20200085873
2020-03-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #111
20200038448
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #112
20200038447
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #113
20200038446
2020-02-06

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #114
20200030426
2020-01-30

TERT immunogenic compositions and methods of treatment using the same

 #115
20200000901
2020-01-02

DNA vector and transformed tumor cell vaccines

 #116
20190307870
2019-10-10

Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

 #117
20190255164
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #118
20190255113
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #119
20190255112
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #120
20190255110
2019-08-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

 #121
20190224236
2019-07-25

Cell-based neoantigen vaccines and uses thereof

 #122
20190185859
2019-06-20

RNA FOR CANCER THERAPY

 #123
20190175713
2019-06-13

Cancer vaccines targeting PRAME and uses thereof

 #124
20190175711
2019-06-13

Cancer vaccines targeting mesothelin and uses thereof

 #125
20190153040
2019-05-23

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

 #126
20190151469
2019-05-23

RNA containing composition for treatment of tumor diseases

 #127
20190083607
2019-03-21

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes

 #128
20190054189
2019-02-21

RNA containing composition for treatment of tumor diseases

 #129
20180333486
2018-11-22

Engineered Cells Expressing Multiple Immunomodulators and Uses Thereof

 #130
20180333485
2018-11-22

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #131
20180326037
2018-11-15

Novel Vaccines Against Multiple Subtypes Of Dengue Virus

 #132
20180207295
2018-07-26

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

 #133
20180125955
2018-05-10

PLACENTAL VACCINATION THERAPY FOR CANCER

 #134
20180117145
2018-05-03

Immunostimulatory compositions, particles, and uses related thereto

 #135
20180085448
2018-03-29

DNA vector and transformed tumor cell vaccines

 #136
20170136109
2017-05-18

DNA vector and transformed tumor cell vaccines

 #137
20170128569
2017-05-11

Engineered cells expressing multiple immunomodulators and uses thereof

 #138
20160361400
2016-12-15

DNA vector and transformed tumor cell vaccines

 #139
20160331844
2016-11-17

RNA containing composition for treatment of tumor diseases

 #140
20160250309
2016-09-01

COMPOSITIONS AND METHODS FOR CANCER TREATMENT

 #141
20160235840
2016-08-18

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #142
20160220651
2016-08-04

Immunogenic tumor associated stromal cell antigen peptides and methods of their use

 #143
20160213771
2016-07-28

Compositions, methods and kits for eliciting an immune response

 #144
20160206718
2016-07-21

Compositions for Liquidation of Tumors

 #145
20160114030
2016-04-28

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #146
20160039889
2016-02-11

Mono or multivalent botulinum neurotoxin based vaccine using the heavy chain from serotypes of

#147
20160022802
2016-01-28

Vaccines against multiple subtypes of dengue virus

 #148
20150273079
2015-10-01

IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING

 #149
20150216957
2015-08-06

PLACENTAL VACCINATION THERAPY FOR CANCER

 #150
20150071987
2015-03-12

IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO

 #151
20150010590
2015-01-08

Immunogenic POTE peptides and methods of use

 #152
20140341941
2014-11-20

HIV consensus envelope sequences and methods for using the same

 #153
20140328870
2014-11-06

Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

 #154
20140314758
2014-10-23

Immunogenic tumor associated stromal cell antigen peptides and methods of their use

 #155
20140220603
2014-08-07

Compositions and methods for detecting microbial infections

 #156
20140186384
2014-07-03

hTERT sequences and methods for using the same

 #157
20130337000
2013-12-19

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

 #158
20130209395
2013-08-15

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #159
20130052221
2013-02-28

DNA-PROTEIN VACCINATION PROTOCOLS

 #160
20130039936
2013-02-14

Immunogenic POTE peptides and methods of use

 #161
20130017224
2013-01-17

Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

 #162
20130004529
2013-01-03

HIV consensus envelope sequences and methods for using the same

 #163
20120244113
2012-09-27

IMMUNOGENIC COMPOSITION AND METHODS

 #164
20120213813
2012-08-23

Alphavirus replicon particles as immunological adjuvants

 #165
20120039842
2012-02-16

Compositions and methods that enhance an immune response

 #166
20120003265
2012-01-05

Immunogenic compositions for inducing an immune response to HIV

 #167
20110280901
2011-11-17

Diagnosis and treatment of infection and Chagas disease

 #168
20110268766
2011-11-03

Engineered cells expressing multiple immunomodulators and uses thereof

 #169
20110151015
2011-06-23

IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING

 #170
20110142887
2011-06-16

Methods and compositions for liquidation of tumors

 #171
20110123491
2011-05-26

Methods and compositions for immunization against chlamydial infection and disease

 #172
20110039916
2011-02-17

Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof

 #173
20110027310
2011-02-03

Compositions and Methods for Cancer Treatment

 #174
20100285061
2010-11-11

DNA immunization protocols

 #175
20100278873
2010-11-04

STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28

 #176
20100233117
2010-09-16

Adjuvant combination formulations

 #177
20100196311
2010-08-05

METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES

 #178
20100166787
2010-07-01

HPV vaccines and methods for using the same

 #179
20100150960
2010-06-17

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE

 #180
20100111899
2010-05-06

Materials and methods for immunizing against FIV infection

 #181
20100003278
2010-01-07

Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof

 #182
20090305418
2009-12-10

Cell therapy method for the treatment of tumors

 #183
20090280143
2009-11-12

Genetic adjuvants for immunotherapy

 #184
20090269364
2009-10-29

HER-2/NEU MULTI-PEPTIDE VACCINE

 #185
20090098165
2009-04-16

Methods and compositions for immunization against chlamydial infection and disease

 #186
20090004142
2009-01-01

Cell therapy method for the treatment of tumors

 #187
20080112925
2008-05-15

QS-21 and IL-12 as an adjuvant combination

 #188
20080063623
2008-03-13

Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines

 #189
20080038297
2008-02-14

GENETIC ADJUVANTS FOR VIRAL VACCINES

 #190
20080003201
2008-01-03

Interleukin-12 as a veterinary vaccine adjuvant

 #191
20070292386
2007-12-20

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

 #192
20070243159
2007-10-18

Therapeutic Compositions and Vaccines By Glycosyl-Phosphatidylinositol (Gpi)-Anchored Cytokines and Immunostimulatory Molecules

 #193
20070190031
2007-08-16

Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv

 #194
20070134200
2007-06-14

Immunogenic composition and methods

 #195
20070110771
2007-05-17

Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP

 #196
20070104731
2007-05-10

Helicobacter proteins and vaccines

 #197
20070087016
2007-04-19

Interleukin-12 as an adjuvant for paramyxoviridae vaccines

 #198
20070026057
2007-02-01

In vivo targeting of dendritic cells

 #199
20070026005
2007-02-01

Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere

 #200
20070025959
2007-02-01

Adjuvant combination formulations

 #201
20060275322
2006-12-07

Modified HCV peptide immunogens

 #202
20060263380
2006-11-23

IL-12 as an adjuvant for Bordetella pertussis vaccines

 #203
20060263379
2006-11-23

IL-12 as an adjuvant for Bordetella pertussis vaccines

 #204
20060257419
2006-11-16

IL-12 as an adjuvant for Bordetella Pertussis vaccines

 #205
20060171917
2006-08-03

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

 #206
20060147467
2006-07-06

Materials and methods for immunizing against FIV infection

 #207
20060121029
2006-06-08

Method and composition for regulating the activity of regulatory t cells

 #208
20050287118
2005-12-29

Bacterial plasmid with immunological adjuvant function and uses thereof

 #209
20050260601
2005-11-24

Recombinant mutants of rhabdovirus and methods of use thereof

 #210
20050244412
2005-11-03

Method and composition for regulating activity of regulatory T cells

 #211
20050238627
2005-10-27

Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer

 #212
20050232897
2005-10-20

Mucosal cytotoxic T lymphocyte responses

 #213
20050197314
2005-09-08

Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines

 #214
20050180951
2005-08-18

Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer

 #215
20050158276
2005-07-21

IL-12 an adjuvant for bordetella pertussis vaccines

 #216
20050129705
2005-06-16

Modified HCV peptide vaccines

 #217
20050031639
2005-02-10

Materials and methods for immunizing against FIV infection

 #218
18606473
2024-10-22

mRNA treatment nanoparticles

 #219
10468618
2015-03-24

Vaccine to protect animals against leishmania